Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: acyclovir

« Back to Dashboard

Summary for Generic Name: acyclovir

Drug Master File Entries: see list53
Suppliers: see list10
Therapeutic Class:Antivirals

Clinical Trials for: acyclovir

Effect of Body Mass on Acyclovir Pharmacokinetics
Status: Active, not recruiting Condition: Hematological Malignancy; Pharmacokinetics of Acyclovir

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Status: Completed Condition: Genital Herpes; HIV Infection

HSV-2 Shedding Resolution After Acyclovir Treatment
Status: Completed Condition: Genital Herpes

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
Status: Completed Condition: HIV Infections; Herpes Genitalis

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
Status: Completed Condition: Genital Herpes

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
Status: Active, not recruiting Condition: Genital Herpes

Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Status: Completed Condition: Herpes Simplex

Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
Status: Completed Condition: Herpes Simplex

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
Status: Completed Condition: HSV Infection; HIV Infection

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
Status: Completed Condition: HIV Infections; Herpesvirus 2, Human

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TABLET;ORAL075211Sep 28, 1998RXNo<disabled><disabled>
Hikma Maple
acyclovir sodium
INJECTABLE;INJECTION074885Dec 19, 1997RXYes<disabled><disabled>
Watson Labs
CAPSULE;ORAL075101Apr 15, 1998DISCNNo<disabled><disabled>
Heritage Pharms Inc
TABLET;ORAL074891Oct 31, 1997DISCNNo<disabled><disabled>
Delcor Asset
TABLET;ORAL020089Apr 30, 1991RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn